ASML heads into the final days of May down 1.3% on the week and 1.2% on the day — a modest retreat that looks almost calm compared to the bruising being taken by its US-listed peers.
The peer divergence is the sharpest signal this week. US semiconductor equipment names have been hit hard: LRCX fell 5.5% over the week, AMAT dropped 5.6%, and MKSI shed a similar 5.7%. ASML's Amsterdam-listed cousin ASM held up better, off just 0.4%, while BESI actually gained 2% on the week. The pattern suggests the sell-off in semis equipment is being felt more acutely across the Atlantic, with European names absorbing less of the pressure — whether from currency effects, relative positioning, or sector rotation remains the open question.
Valuation has continued to compress quietly. The P/E has eased another point over the past seven days to 35.7x, building on the contraction flagged in the previous note when it stood at 36.3x. The EV/EBITDA multiple has pulled back a further half-point to 27.6x over the same period. Both moves are directionally consistent with what was observed over the past month — the market is assigning a smaller premium to each unit of earnings than it was 30 days ago, even though forward EPS estimate momentum has remained constructive. The earnings yield, now 2.8%, has nudged higher as the multiple recedes. An ORTEX quality score of 90.3 and an F-Score of 8 speak to the durability of the underlying business — the compression reflects valuation recalibration, not deteriorating fundamentals.
The lending market carries no signal worth trading around. Short interest is negligible — effectively zero as a fraction of the free float — and borrow availability is fully open, with hundreds of millions of shares available. Cost to borrow has drifted back down to 0.63% after touching 0.84% last week, itself unremarkable at this level. The short score of 25.4 sits near the bottom of the universe, consistent with a name where no active bearish thesis has taken hold. There is no squeeze pressure, no meaningful borrow constraint, and no crowding dynamic to speak of.
Institutional ownership tells a structurally supportive story. BlackRock holds 7.2% of shares, Vanguard 4.5%, with Fidelity and Capital Research each adding modestly in the most recent reporting period. The ownership base is deep and passive-heavy — the kind of structure that tends to dampen volatility rather than amplify it. Insider activity from February showed routine award-and-sell patterns from the CEO, CFO, and COO — compensation-driven rather than directional, and now almost three months stale. The one genuine buy in the data, a supervisory board member purchasing shares at €1,180 in mid-February, was small in scale.
The next scheduled event is Q2 results on July 15. With the stock now trading at €1,249 — well below the $1,502 level cited in Monday's stock report (which was denominated in USD on a US ADR basis) — the July print will be the next hard test of whether the beat-and-fade pattern that defined the April earnings release repeats. That April event saw the stock drop nearly 5% on the day and a further 2.7% over the following week. How the market responds to the next print, given the multiple has already compressed and sector sentiment has softened, is the cleaner question to carry into June.
See the live data behind this article on ORTEX.
Open ASML on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
